The DNA damage response arouses the immune system
- PMID: 16618710
- DOI: 10.1158/0008-5472.CAN-05-4603
The DNA damage response arouses the immune system
Abstract
Although there is considerable knowledge of how DNA damage triggers cell cycle arrest, DNA repair, and apoptosis, little was known about its potential role in immune responses. Recently, we showed that genotoxic stress and stalled DNA replication forks induce the expression of ligands for the NKG2D receptor found in natural killer cells and certain T cells, cell types that are able to attack tumor cells. Chronic activation of this response in tumor cells may contribute to immune recognition, but it also imposes a selection mechanism for immune escape and malignant progression. This unique arm of the DNA damage response may have implications for understanding therapeutic responses, many of which induce the DNA damage response, and for designing more effective regimens to treat cancer.
Similar articles
-
DNA damage response and development of targeted cancer treatments.Ann Med. 2007;39(6):457-64. doi: 10.1080/07853890701436773. Epub 2007 Jul 31. Ann Med. 2007. PMID: 17852036 Review.
-
The DNA damage response, immunity and cancer.Semin Cancer Biol. 2006 Oct;16(5):344-7. doi: 10.1016/j.semcancer.2006.07.004. Epub 2006 Jul 7. Semin Cancer Biol. 2006. PMID: 16914325 Review.
-
NKG2D ligands: key targets of the immune response.Trends Immunol. 2008 Aug;29(8):397-403. doi: 10.1016/j.it.2008.04.007. Epub 2008 Jul 3. Trends Immunol. 2008. PMID: 18602338 Review.
-
Innate immune recognition and suppression of tumors.Adv Cancer Res. 2006;95:293-322. doi: 10.1016/S0065-230X(06)95008-8. Adv Cancer Res. 2006. PMID: 16860661 Review.
-
The NKG2D receptor: sensing stressed cells.Trends Mol Med. 2008 Apr;14(4):179-89. doi: 10.1016/j.molmed.2008.02.004. Epub 2008 Mar 18. Trends Mol Med. 2008. PMID: 18353724 Review.
Cited by
-
Oncolytic adenovirus coding for shedding-resistant MICA enhances immune responses against tumors.Cancer Immunol Immunother. 2024 Jan 5;73(1):5. doi: 10.1007/s00262-023-03611-3. Cancer Immunol Immunother. 2024. PMID: 38180524 Free PMC article.
-
At the Crossroads of the cGAS-cGAMP-STING Pathway and the DNA Damage Response: Implications for Cancer Progression and Treatment.Pharmaceuticals (Basel). 2023 Dec 1;16(12):1675. doi: 10.3390/ph16121675. Pharmaceuticals (Basel). 2023. PMID: 38139802 Free PMC article. Review.
-
Competition for H2A.Z underlies the developmental impacts of repetitive element de-repression.Development. 2023 Nov 1;150(21):dev202338. doi: 10.1242/dev.202338. Epub 2023 Nov 8. Development. 2023. PMID: 37938830
-
Natural-Product-Derived Adjunctive Treatments to Conventional Therapy and Their Immunoregulatory Activities in Triple-Negative Breast Cancer.Molecules. 2023 Aug 1;28(15):5804. doi: 10.3390/molecules28155804. Molecules. 2023. PMID: 37570775 Free PMC article. Review.
-
Human cytomegalovirus UL138 interaction with USP1 activates STAT1 in infection.PLoS Pathog. 2023 Jun 8;19(6):e1011185. doi: 10.1371/journal.ppat.1011185. eCollection 2023 Jun. PLoS Pathog. 2023. PMID: 37289831 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
